Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2783-2791
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2783
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2783
Table 1 Comparison of baseline data between the single and combined groups
| Group | Gender | Age (yr) | Tumor number (cases) | Tumor diameter (cm) | ||
| Male | Female | Single | Multiple | |||
| Combined group (n = 75) | 41 (54.67) | 34 (45.33) | 53.05 ± 13.43 | 47 (62.67) | 28 (37.33) | 5.11 ± 1.27 |
| Single group (n = 75) | 43 (57.33) | 32 (42.67) | 52.51 ± 12.06 | 49 (65.33) | 26 (34.67) | 5.49 ± 1.23 |
| χ2/t value | 0.108 | -0.558 | 0.262 | -1.900 | ||
| P value | 0.742 | 0.580 | 0.793 | 0.059 | ||
- Citation: Lin ZP, Huang DB, Zou XG, Chen Y, Li XQ, Zhang J. Percutaneous microwave ablation and transcatheter arterial chemoembolization for serum tumor markers and prognostics of middle-late primary hepatic carcinoma. World J Gastrointest Surg 2023; 15(12): 2783-2791
- URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2783.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2783